BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 30429105)

  • 1. PAI-1 secreted from metastatic ovarian cancer cells triggers the tumor-promoting role of the mesothelium in a feedback loop to accelerate peritoneal dissemination.
    Peng Y; Kajiyama H; Yuan H; Nakamura K; Yoshihara M; Yokoi A; Fujikake K; Yasui H; Yoshikawa N; Suzuki S; Senga T; Shibata K; Kikkawa F
    Cancer Lett; 2019 Feb; 442():181-192. PubMed ID: 30429105
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transforming growth factor-beta1 produced by ovarian cancer cell line HRA stimulates attachment and invasion through an up-regulation of plasminogen activator inhibitor type-1 in human peritoneal mesothelial cells.
    Hirashima Y; Kobayashi H; Suzuki M; Tanaka Y; Kanayama N; Terao T
    J Biol Chem; 2003 Jul; 278(29):26793-802. PubMed ID: 12743121
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GRO-α and IL-8 enhance ovarian cancer metastatic potential via the CXCR2-mediated TAK1/NFκB signaling cascade.
    Yung MM; Tang HW; Cai PC; Leung TH; Ngu SF; Chan KK; Xu D; Yang H; Ngan HY; Chan DW
    Theranostics; 2018; 8(5):1270-1285. PubMed ID: 29507619
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mesothelial vitronectin stimulates migration of ovarian cancer cells.
    Heyman L; Leroy-Dudal J; Fernandes J; Seyer D; Dutoit S; Carreiras F
    Cell Biol Int; 2010 Apr; 34(5):493-502. PubMed ID: 20121701
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interactions of human peritoneal mesothelial cells with serous ovarian cancer cell spheroids--evidence for a mechanical and paracrine barrier function of the peritoneal mesothelium.
    Stadlmann S; Feichtinger H; Mikuz G; Marth C; Zeimet AG; Herold M; Knabbe C; Offner FA
    Int J Gynecol Cancer; 2014 Feb; 24(2):192-200. PubMed ID: 24407573
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Host Mesothelin Expression Increases Ovarian Cancer Metastasis in the Peritoneal Microenvironment.
    Hilliard TS; Kowalski B; Iwamoto K; Agadi EA; Liu Y; Yang J; Asem M; Klymenko Y; Johnson J; Shi Z; Marfowaa G; Yemc MG; Petrasko P; Stack MS
    Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830322
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Malignant extracellular vesicles carrying MMP1 mRNA facilitate peritoneal dissemination in ovarian cancer.
    Yokoi A; Yoshioka Y; Yamamoto Y; Ishikawa M; Ikeda SI; Kato T; Kiyono T; Takeshita F; Kajiyama H; Kikkawa F; Ochiya T
    Nat Commun; 2017 Mar; 8():14470. PubMed ID: 28262727
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endothelial cells promote triple-negative breast cancer cell metastasis
    Zhang W; Xu J; Fang H; Tang L; Chen W; Sun Q; Zhang Q; Yang F; Sun Z; Cao L; Wang Y; Guan X
    FASEB J; 2018 Jan; 32(1):276-288. PubMed ID: 28899878
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ovarian cancer-associated mesothelial cells induce acquired platinum-resistance in peritoneal metastasis via the FN1/Akt signaling pathway.
    Yoshihara M; Kajiyama H; Yokoi A; Sugiyama M; Koya Y; Yamakita Y; Liu W; Nakamura K; Moriyama Y; Yasui H; Suzuki S; Yamamoto Y; Ricciardelli C; Nawa A; Shibata K; Kikkawa F
    Int J Cancer; 2020 Apr; 146(8):2268-2280. PubMed ID: 31904865
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting carcinoma-associated mesothelial cells with antibody-drug conjugates in ovarian carcinomatosis.
    Pascual-Antón L; Sandoval P; González-Mateo GT; Kopytina V; Tomero-Sanz H; Arriero-País EM; Jiménez-Heffernan JA; Fabre M; Egaña I; Ferrer C; Simón L; González-Cortijo L; Sainz de la Cuesta R; López-Cabrera M
    J Pathol; 2023 Oct; 261(2):238-251. PubMed ID: 37555348
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proteomic analysis of cancer and mesothelial cells reveals an increase in Mucin 5AC during ovarian cancer and peritoneal interaction.
    Musrap N; Karagiannis GS; Saraon P; Batruch I; Smith C; Diamandis EP
    J Proteomics; 2014 May; 103():204-15. PubMed ID: 24726482
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Collagen Remodeling in the Hypoxic Tumor-Mesothelial Niche Promotes Ovarian Cancer Metastasis.
    Natarajan S; Foreman KM; Soriano MI; Rossen NS; Shehade H; Fregoso DR; Eggold JT; Krishnan V; Dorigo O; Krieg AJ; Heilshorn SC; Sinha S; Fuh KC; Rankin EB
    Cancer Res; 2019 May; 79(9):2271-2284. PubMed ID: 30862717
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CCL2 secreted from cancer-associated mesothelial cells promotes peritoneal metastasis of ovarian cancer cells through the P38-MAPK pathway.
    Yasui H; Kajiyama H; Tamauchi S; Suzuki S; Peng Y; Yoshikawa N; Sugiyama M; Nakamura K; Kikkawa F
    Clin Exp Metastasis; 2020 Feb; 37(1):145-158. PubMed ID: 31541326
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vascular cell adhesion molecule-1 is a regulator of ovarian cancer peritoneal metastasis.
    Slack-Davis JK; Atkins KA; Harrer C; Hershey ED; Conaway M
    Cancer Res; 2009 Feb; 69(4):1469-76. PubMed ID: 19208843
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LC-MS/MS analysis of ovarian cancer metastasis-related proteins using a nude mouse model: 14-3-3 zeta as a candidate biomarker.
    He Y; Wu X; Liu X; Yan G; Xu C
    J Proteome Res; 2010 Dec; 9(12):6180-90. PubMed ID: 21028892
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peritoneal mesothelium promotes the progression of ovarian cancer cells in vitro and in a mice xenograft model in vivo.
    Mikuła-Pietrasik J; Sosińska P; Kucińska M; Murias M; Maksin K; Malińska A; Ziółkowska A; Piotrowska H; Woźniak A; Książek K
    Cancer Lett; 2014 Dec; 355(2):310-5. PubMed ID: 25301450
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ligand-dependent EGFR activation induces the co-expression of IL-6 and PAI-1 via the NFkB pathway in advanced-stage epithelial ovarian cancer.
    Alberti C; Pinciroli P; Valeri B; Ferri R; Ditto A; Umezawa K; Sensi M; Canevari S; Tomassetti A
    Oncogene; 2012 Sep; 31(37):4139-49. PubMed ID: 22158046
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of plasminogen activator inhibitor-1 is a potential therapeutic strategy in ovarian cancer.
    Mashiko S; Kitatani K; Toyoshima M; Ichimura A; Dan T; Usui T; Ishibashi M; Shigeta S; Nagase S; Miyata T; Yaegashi N
    Cancer Biol Ther; 2015; 16(2):253-60. PubMed ID: 25587663
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatocyte growth factor secreted by ovarian cancer cells stimulates peritoneal implantation via the mesothelial-mesenchymal transition of the peritoneum.
    Nakamura M; Ono YJ; Kanemura M; Tanaka T; Hayashi M; Terai Y; Ohmichi M
    Gynecol Oncol; 2015 Nov; 139(2):345-54. PubMed ID: 26335595
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Filopodia play an important role in the trans-mesothelial migration of ovarian cancer cells.
    Yoshihara M; Yamakita Y; Kajiyama H; Senga T; Koya Y; Yamashita M; Nawa A; Kikkawa F
    Exp Cell Res; 2020 Jul; 392(2):112011. PubMed ID: 32339607
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.